Literature DB >> 29600916

Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease.

Meng Zhao1,1, Xiaofeng Deng1,1, Dong Zhang1,1, Shuo Wang1,1, Yan Zhang1,1, Rong Wang1,1, Jizong Zhao1,1.   

Abstract

OBJECTIVEThe risk factors and clinical significance of postoperative complications in moyamoya disease are still unclear. The aim of this study was to investigate the predictors of postoperative complications in moyamoya disease and examine the impact of complications on outcomes.METHODSThe authors reviewed consecutive cases involving adult moyamoya disease patients who underwent indirect, direct, or combined bypass surgery in their hospital between 2009 and 2015. Preoperative clinical characteristics and radiographic features were recorded. Postoperative complications within 14 days after surgery were examined. Multivariate logistic regression analyses were performed to identify the risk factors for either postoperative ischemia or postoperative cerebral hyperperfusion. Outcome data, including recurrent strokes and neurological status (modified Rankin Scale [mRS]) during follow-up, were collected. Outcomes were compared between patients who had complications with those without complications, using propensity-score analysis to account for between-group differences in baseline characteristics.RESULTSA total of 500 patients (610 hemispheres) were included in this study. Postoperative complications were observed in 74 operations (12.1%), including new postoperative ischemia in 30 cases (4.9%), hyperperfusion in 27 (4.4%), impaired wound healing in 12 (2.0%), and subdural effusion in 6 (1.0%). The complication rates for different surgery types were as follows: 12.6% (n = 25) for indirect bypass, 12.7% (n = 37) for direct bypass, and 10.0% (n = 12) for combined bypass (p = 0.726). Postoperative ischemic complications occurred in 30 hemispheres (4.9%) in 30 different patients, and postoperative symptomatic hyperperfusion occurred after 27 procedures (4.4%). Advanced Suzuki stage (OR 1.669, 95% CI 1.059-2.632, p = 0.027) and preoperative ischemic presentation (OR 5.845, 95% CI 1.654-20.653, p = 0.006) were significantly associated with postoperative ischemia. Preoperative ischemic presentation (OR 5.73, 95% CI 1.27-25.88, p = 0.023) and admission modified Rankin Scale (mRS) score (OR 1.81, 95% CI 1.06-3.10, p = 0.031) were significantly associated with symptomatic postoperative cerebral hyperperfusion syndrome (CHS). Compared with patients without postoperative complications, patients who experienced any postoperative complications had longer hospital stays and worse mRS scores at discharge (both p < 0.0001). At the final follow-up, no significant differences in functional disability (mRS score 3-6, 11.9% vs 4.5%, p = 0.116) and future stroke events (p = 0.513) between the 2 groups were detected.CONCLUSIONSAdvanced Suzuki stage and preoperative ischemic presentation were independent risk factors for postoperative ischemia; the mRS score on admission and preoperative ischemic presentation were independently associated with postoperative CHS. Although patients with postoperative complications had worse neurological status at discharge, postoperative complications had no associations with future stroke events or functional disability during follow-up.

Entities:  

Keywords:  CHS = cerebral hyperperfusion syndrome; DSA = digital subtraction angiography; EDAS = encephaloduroarteriosynangiosis; ICA = internal carotid artery; MCA = middle cerebral artery; MMD = moyamoya disease; MRA = MR angiography; PCA = posterior cerebral artery; STA = superficial temporal artery; TIA = transient ischemic attack; adult; complication; mRS = modified Rankin Scale; moyamoya disease; outcome; revascularization; stroke; vascular disorders

Year:  2018        PMID: 29600916     DOI: 10.3171/2017.10.JNS171749

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease.

Authors:  Takeshi Mikami; Hime Suzuki; Ryo Ukai; Katsuya Komatsu; Yukinori Akiyama; Masahiko Wanibuchi; Kiyohiro Houkin; Nobuhiro Mikuni
Journal:  Neurosurg Rev       Date:  2019-02-14       Impact factor: 3.042

2.  High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease.

Authors:  Jiaxi Li; Yahui Zhao; Meng Zhao; Penghui Cao; Xingju Liu; Hao Ren; Dong Zhang; Yan Zhang; Rong Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2019-06-15       Impact factor: 3.042

3.  Effects of Aspirin Therapy on Bypass Efficacy and Survival of Patients Receiving Direct Cerebral Revascularization.

Authors:  Yanxiao Xiang; Ping Zhang; Peng Zhao; Tao Sun; Fei Wang; Yiming He; Donghai Wang; Anchang Liu
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

4.  Multimodal neuronavigation-guided precision bypass in adult ischaemic patients with moyamoya disease: study protocol for a randomised controlled trial.

Authors:  Junlin Lu; Yahui Zhao; Li Ma; Yu Chen; Mingtao Li; Xun Ye; Rong Wang; Xiaolin Chen; Yuanli Zhao
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

5.  Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy.

Authors:  Dominique Hervé; Nathanaelle Ibos-Augé; Lionel Calvière; Christina Rogan; Marc Antoine Labeyrie; Jean Pierre Guichard; Ophélia Godin; Manoelle Kossorotoff; Marie Odile Habert; Elisabeth Tournier Lasserve; Sylvie Chevret; Hugues Chabriat
Journal:  Neurology       Date:  2019-06-25       Impact factor: 9.910

6.  Effects of end-tidal carbon dioxide levels in patients undergoing direct revascularization for Moyamoya disease and risk factors associated with postoperative complications.

Authors:  Tingting Song; Xiancun Liu; Rui Han; Lihua Huang; Jingjing Zhang; Haiyang Xu
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

7.  Cerebral Ischemic Complications After Surgical Revascularization for Moyamoya Disease: Risk Factors and Development of a Predictive Model Based on Preoperative Nutritional Blood Parameters.

Authors:  Fangbao Li; Chuanfeng Li; Yunwei Sun; Yue Bao; Wenbo Jiang; Zuoyan Song; Yongyi Wang; Mingxing Liu; Weimin Wang; Tong Li; Luo Li
Journal:  Front Nutr       Date:  2022-03-10

8.  CRISPR Detection and Research on Screening Mutant Gene TTN of Moyamoya Disease Family Based on Whole Exome Sequencing.

Authors:  Yilei Xiao; Weidong Liu; Jiheng Hao; Qunlong Jiang; Xingbang Wang; Donghu Yu; Liyong Zhang; Zhaogang Dong; Jiyue Wang
Journal:  Front Mol Biosci       Date:  2022-03-09

9.  Risk factors for postoperative ischemic complications in pediatric moyamoya disease.

Authors:  Xiaofeng Deng; Peicong Ge; Rong Wang; Dong Zhang; Jizong Zhao; Yan Zhang
Journal:  BMC Neurol       Date:  2021-06-22       Impact factor: 2.474

10.  Effects and safety of aspirin use in patients after cerebrovascular bypass procedures.

Authors:  Junlin Lu; Guangchao Shi; Yuanli Zhao; Rong Wang; Dong Zhang; Xiaolin Chen; Hao Wang; Ji Zong Zhao
Journal:  Stroke Vasc Neurol       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.